[go: up one dir, main page]

AU2001263090A1 - Tnf and ifn stimulated genes and uses therefor - Google Patents

Tnf and ifn stimulated genes and uses therefor

Info

Publication number
AU2001263090A1
AU2001263090A1 AU2001263090A AU6309001A AU2001263090A1 AU 2001263090 A1 AU2001263090 A1 AU 2001263090A1 AU 2001263090 A AU2001263090 A AU 2001263090A AU 6309001 A AU6309001 A AU 6309001A AU 2001263090 A1 AU2001263090 A1 AU 2001263090A1
Authority
AU
Australia
Prior art keywords
tnf
uses therefor
stimulated genes
ifn stimulated
ifn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263090A
Inventor
Grace Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Serono Research and Development Institute Inc
Original Assignee
Serono Reproductive Biology Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Reproductive Biology Institute Inc filed Critical Serono Reproductive Biology Institute Inc
Publication of AU2001263090A1 publication Critical patent/AU2001263090A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866Interferon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001263090A 2000-05-12 2001-05-11 Tnf and ifn stimulated genes and uses therefor Abandoned AU2001263090A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20362400P 2000-05-12 2000-05-12
US60/203,624 2000-05-12
PCT/US2001/015402 WO2001088180A2 (en) 2000-05-12 2001-05-11 Tnf and ifn stimulated genes and uses therefor

Publications (1)

Publication Number Publication Date
AU2001263090A1 true AU2001263090A1 (en) 2001-11-26

Family

ID=22754683

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263090A Abandoned AU2001263090A1 (en) 2000-05-12 2001-05-11 Tnf and ifn stimulated genes and uses therefor

Country Status (4)

Country Link
US (1) US20020164299A1 (en)
EP (1) EP1287156A2 (en)
AU (1) AU2001263090A1 (en)
WO (1) WO2001088180A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06504912A (en) * 1991-01-14 1994-06-09 ニューヨーク・ユニバーシティ Cytokine-inducing protein TSG-6, DNA encoding the TSG-6 protein, and use of the TSG-6 protein
JPH06506195A (en) * 1991-01-14 1994-07-14 ニューヨーク ユニバシテイ Cytokine-induced protein, TSG-14, DNA encoding therefor and uses thereof

Also Published As

Publication number Publication date
WO2001088180A3 (en) 2002-12-05
US20020164299A1 (en) 2002-11-07
WO2001088180A2 (en) 2001-11-22
EP1287156A2 (en) 2003-03-05

Similar Documents

Publication Publication Date Title
AU2342900A (en) Novel interferon stimulated and repressed genes
AU7338200A (en) User interface display and method
AU5091201A (en) Vegf-modulated genes and methods employing them
AU4943200A (en) Modified cytokine
AU1344400A (en) Inflammation-associated genes
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2088801A (en) Metastasis genes and uses thereof
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ659800A0 (en) Genetic sequences and uses therefor
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001293074A1 (en) Human liver cell line
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2003223878A1 (en) Heating conductor and use thereof
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2003263895A1 (en) Contraceptive methods and formulations
AU1894601A (en) Novel gene and use thereof
AU2001263090A1 (en) Tnf and ifn stimulated genes and uses therefor
AU2669201A (en) Taccalonolides and their use
AU5979300A (en) Angiopoietin-6 and uses thereof
GB0020952D0 (en) Genes and proteins and their uses
AU2001277519A1 (en) Bio-probes and use thereof